Manganese-enhanced MRI optic nerve tracking: effect of intravitreal manganese dose on retinal toxicity

Lisha Luo1, Hui Xu, Ying Li

  • 1Peking University Eye Center, Peking University Third Hospital, Beijing, China.

NMR in Biomedicine
|May 11, 2012
PubMed

Insights

Manganese-enhanced MRI (MEMRI) visual pathway studies in rats show retinal ganglion cell damage starting at 25 mM MnCl₂. Optimal MEMRI requires intravitreal MnCl₂ concentrations not exceeding 25 mM to avoid retinal toxicity.

Area of Science:

  • Neuroimaging
  • Ophthalmology
  • Toxicology

Background:

  • Manganese-enhanced MRI (MEMRI) is a neuroimaging technique.
  • Assessing MEMRI dose dependence and retinal toxicity is crucial for visual pathway studies.

Purpose of the Study:

  • Determine the dose-dependent effects of manganese chloride (MnCl₂) on visual pathway MEMRI in rats.
  • Evaluate the retinal toxicity of intravitreally injected MnCl₂.

Main Methods:

  • Intravitreal injections of varying MnCl₂ concentrations (0-300 mM) in Sprague-Dawley rats.
  • Measurement of optic nerve contrast-to-noise ratio (CNR) for MEMRI.
  • Retinal ganglion cell counting and histological examination (light and transmission electron microscopy) to assess toxicity.

Main Results:

  • Optic nerve CNR increased with MnCl₂ concentration up to 75 mM.
  • Significant reduction in retinal ganglion cell density observed at MnCl₂ concentrations of 75 mM and above.
  • Early signs of retinal toxicity, including increased ribosomes in ganglion cells, detected at 25 mM MnCl₂.

Conclusions:

  • Intravitreal MnCl₂ induces retinal cell damage, beginning at concentrations as low as 25 mM.
  • For visual pathway MEMRI in rats, intravitreal MnCl₂ concentration should not exceed 25 mM to mitigate retinal toxicity.

Related Concept Videos